Literature DB >> 8035836

The role of low-affinity interleukin-2 receptors in autocrine ligand binding: alternative mechanisms for enhanced binding effect.

K E Forsten1, D A Lauffenburger.   

Abstract

T-cell proliferation is regulated by the autocrine ligand interleukin-2 (IL-2), for which these cells possess dual, low-affinity and high-affinity receptor populations. Proliferation stimulated by IL-2 is dependent upon ligand binding to p75, a component of the high-affinity receptor. As with other cells exhibiting dual receptor systems, a central question is, therefore: what is the role of the low-affinity receptor population? We apply a mathematical modeling approach to examine three alternative mechanisms that have been suggested for the role of low-affinity receptors: a ligand reservoir, a receptor reservoir, and a ligand carrier. Using model parameter values specific to the IL-2/T-cell system, we find that only the ligand carrier mechanism leads to binding of autocrine ligand to high-affinity receptors that is increased over levels found on a single, pre-formed high-affinity receptor population. With the ligand reservoir and the receptor reservoir mechanisms, the presence of the low-affinity receptors actually diminishes high-affinity receptor binding due to competition. In contrast, excess low-affinity receptors can act to enhance the level of high-affinity receptor complexes when membrane transport is included, indicating that should this mechanism be inhibited, cell response could potentially be reduced or eliminated. The ligand carrier effect is especially significant for cells expressing a large number (> 10(5) receptors/cell) low-affinity receptors, and at low cell densities (< 10(4) cells/ml). This may at least partially account for the behavior demonstrated by early phase adult T-cell leukemia cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8035836     DOI: 10.1016/0161-5890(94)90148-1

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  8 in total

1.  Spatial range of autocrine signaling: modeling and computational analysis.

Authors:  S Y Shvartsman; H S Wiley; W M Deen; D A Lauffenburger
Journal:  Biophys J       Date:  2001-10       Impact factor: 4.033

2.  Ligand accumulation in autocrine cell cultures.

Authors:  Michael I Monine; Alexander M Berezhkovskii; Elizabeth J Joslin; H Steven Wiley; Douglas A Lauffenburger; Stanislav Y Shvartsman
Journal:  Biophys J       Date:  2005-01-14       Impact factor: 4.033

3.  Time and length scales of autocrine signals in three dimensions.

Authors:  Mathieu Coppey; Alexander M Berezhkovskii; Stuart C Sealfon; Stanislav Y Shvartsman
Journal:  Biophys J       Date:  2007-09-15       Impact factor: 4.033

4.  Approximating the effects of diffusion on reversible reactions at the cell surface: ligand-receptor kinetics.

Authors:  B Goldstein; M Dembo
Journal:  Biophys J       Date:  1995-04       Impact factor: 4.033

5.  Crystal structure of the IL-2 signaling complex: paradigm for a heterotrimeric cytokine receptor.

Authors:  Deborah J Stauber; Erik W Debler; Patricia A Horton; Kendall A Smith; Ian A Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-13       Impact factor: 11.205

6.  Dimerization of VEGF receptors and implications for signal transduction: a computational study.

Authors:  Feilim Mac Gabhann; Aleksander S Popel
Journal:  Biophys Chem       Date:  2007-03-24       Impact factor: 2.352

7.  Single-cell quantification of IL-2 response by effector and regulatory T cells reveals critical plasticity in immune response.

Authors:  Ofer Feinerman; Garrit Jentsch; Karen E Tkach; Jesse W Coward; Matthew M Hathorn; Michael W Sneddon; Thierry Emonet; Kendall A Smith; Grégoire Altan-Bonnet
Journal:  Mol Syst Biol       Date:  2010-11-30       Impact factor: 11.429

8.  Balancing speed and accuracy of polyclonal T cell activation: a role for extracellular feedback.

Authors:  Yonatan Savir; Nir Waysbort; Yaron E Antebi; Tsvi Tlusty; Nir Friedman
Journal:  BMC Syst Biol       Date:  2012-08-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.